Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 5 (2008), Issue 7 (July)

1. Rheumatoid arthritis as a risk factor for a narrow C-2 pedicle: 3D analysis of the C-2 pedicle screw trajectory.
   J Neurosurg Spine, 9(1): 17-21. [Abstract] [Full-text]
2. Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis.
   Proc Natl Acad Sci U S A, 105(26): 9017-22. [Abstract] [Full-text]
3. The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.
   Ann Rheum Dis, 67(8): 1174-7. [Abstract] [Full-text]
4. Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial.
   Ann Rheum Dis, 67(8): 1084-9. [Abstract] [Full-text]
5. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.
   Ann Rheum Dis, 67(8): 1096-103. [Abstract] [Full-text]
6. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.
   Ann Rheum Dis, 67(8): 1139-44. [Abstract] [Full-text]
7. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.
   Ann Rheum Dis, 67(8): 1090-5. [Abstract] [Full-text]
8. Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis.
   Ann Rheum Dis, 67(8): 1111-5. [Abstract] [Full-text]
9. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
   Ann Rheum Dis, 67(8): 1145-52. [Abstract] [Full-text]
10. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Ann Rheum Dis, 67(8): 1153-8. [Abstract] [Full-text]
11. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.
    Ann Rheum Dis, 67(8): 1132-8. [Abstract] [Full-text]
12. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
    Ann Rheum Dis, 67(8): 1127-31. [Abstract] [Full-text]
13. A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis.
    Ann Rheum Dis, 67(8): 1159-64. [Abstract] [Full-text]
14. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
    Ann Rheum Dis, 67(8): 1104-10. [Abstract] [Full-text]
15. Interstitial granulomatous drug reaction to anakinra.
    J Am Acad Dermatol, 59(2): S25-7. [Abstract] [Full-text]
16. The internet-based arthritis self-management program: a one-year randomized trial for patients with arthritis or fibromyalgia.
    Arthritis Rheum, 59(7): 1009-17. [Abstract] [Full-text]
17. Rheumatoid arthritis patients' perceptions of mutuality in conversations with spouses/partners and their links with psychological and physical health.
    Arthritis Rheum, 59(7): 921-8. [Abstract] [Full-text]
18. Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome.
    Arthritis Rheum, 59(7): 911-20. [Abstract] [Full-text]
19. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
    Arthritis Rheum, 59(7): 905-10. [Abstract] [Full-text]
20. Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum, 59(7): 984-8. [Abstract] [Full-text]
21. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome.
    Clin Immunol, 128(2): 269-76. [Abstract] [Full-text]
22. Role of GADD45 beta in the regulation of synovial fluid T cell apoptosis in rheumatoid arthritis.
    Clin Immunol, 128(2): 238-47. [Abstract] [Full-text]
23. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility.
    Hum Mol Genet, 17(15): 2274-9. [Abstract] [Full-text]
24. Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats.
    J Pharmacol Exp Ther, 326(2): 532-45. [Abstract] [Full-text]
25. Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis.
    J Pharmacol Exp Ther, 326(2): 546-54. [Abstract] [Full-text]
26. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Clin Biochem, 41(12): 955-9. [Abstract] [Full-text]
27. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
    Am Heart J, 156(2): 336-41. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.